CVS HEALTH Corp financial data

Symbol
CVS on NYSE
Industry
Retail-Drug Stores and Proprietary Stores
Location
One Cvs Dr., Woonsocket, Rhode Island
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CVS CAREMARK CORP (to 9/3/2014), CVS/CAREMARK CORP (to 5/8/2007), CVS CORP (to 3/22/2007), MELVILLE CORP (to 1/10/1997)
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 84.5 % -8.93%
Quick Ratio 21.5 % -15.6%
Debt-to-equity 236 % +6.66%
Return On Equity 9.82 % +74.2%
Return On Assets 2.93 % +65.8%
Operating Margin 3.48 % +46.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.26B shares -2.08%
Common Stock, Shares, Outstanding 1.25B shares -2.11%
Entity Public Float 88.5B USD -27%
Common Stock, Value, Issued 18M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.26B shares -1.79%
Weighted Average Number of Shares Outstanding, Diluted 1.27B shares -1.86%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 361B USD +9.07%
Costs and Expenses 348B USD +7.83%
Operating Income (Loss) 12.6B USD +60%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9.87B USD +72.8%
Income Tax Expense (Benefit) 2.52B USD +57.8%
Net Income (Loss) Attributable to Parent 7.32B USD +78.9%
Earnings Per Share, Basic 5.71 USD/shares +80.7%
Earnings Per Share, Diluted 5.7 USD/shares +81.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.8B USD -33%
Accounts Receivable, after Allowance for Credit Loss, Current 32.2B USD +13.7%
Inventory, Net 16.3B USD -10.5%
Other Assets, Current 5.82B USD +54.5%
Assets, Current 67.5B USD -1.8%
Property, Plant and Equipment, Net 13B USD +3.14%
Operating Lease, Right-of-Use Asset 17B USD -3.48%
Intangible Assets, Net (Excluding Goodwill) 28.8B USD +9.11%
Goodwill 91.3B USD +8.58%
Other Assets, Noncurrent 4.8B USD -0.48%
Assets 250B USD +4.35%
Accrued Liabilities, Current 22.4B USD +3.88%
Contract with Customer, Liability, Current 117M USD -14%
Liabilities, Current 83.3B USD +11%
Long-term Debt and Lease Obligation 57.7B USD +2.2%
Deferred Income Tax Liabilities, Net 4.18B USD +2.17%
Operating Lease, Liability, Noncurrent 15.7B USD -5%
Other Liabilities, Noncurrent 6.21B USD -6.99%
Liabilities 176B USD +4.68%
Common Stocks, Including Additional Paid in Capital 49.2B USD +1.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax -341M USD +61%
Retained Earnings (Accumulated Deficit) 61.9B USD +7.13%
Stockholders' Equity Attributable to Parent 74B USD +3.62%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 74.2B USD +3.59%
Liabilities and Equity 250B USD +4.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.9B USD -34.1%
Net Cash Provided by (Used in) Financing Activities -1.23B USD -145%
Net Cash Provided by (Used in) Investing Activities -2.09B USD +75.4%
Common Stock, Shares Authorized 3.2B shares 0%
Common Stock, Shares, Issued 1.77B shares +0.68%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.58B USD -4.12%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.1B USD -32.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.04B USD +34.9%
Deferred Tax Assets, Valuation Allowance 385M USD -27.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 17.8B USD -4.12%
Depreciation 2.5B USD +4.17%
Payments to Acquire Property, Plant, and Equipment 705M USD -28.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 7.86B USD +115%
Lessee, Operating Lease, Liability, to be Paid 22.9B USD -4.93%
Property, Plant and Equipment, Gross 34.6B USD +3.13%
Operating Lease, Liability, Current 1.91B USD +13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.56B USD +2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.72B USD +1.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -676M USD +66.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.08B USD -7.69%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.37B USD +2.42%
Deferred Tax Assets, Operating Loss Carryforwards 409M USD +53.8%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -537M USD +64.8%
Current Income Tax Expense (Benefit) 3.48B USD -1.61%
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 436M USD -2.24%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.18B USD +1.82%
Operating Lease, Payments 2.76B USD +2.49%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 662M USD -9.93%
Current Federal Tax Expense (Benefit) 2.82B USD +0.57%
Amortization of Intangible Assets 2.01B USD +16.6%
Depreciation, Depletion and Amortization 1.14B USD +13.7%
Deferred Tax Assets, Net of Valuation Allowance 8B USD +0.21%
Share-based Payment Arrangement, Expense 588M USD +31.5%
Deferred State and Local Income Tax Expense (Benefit) -139M USD +72.4%
Interest Expense 2.79B USD +21.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%